Skip to content

Clinical trials

Completed Phase 1 trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Status: Completed Country / region: Hong Kong Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20072
20081
20095
20106
20112
20123
20135
20145
20157
20163
20178
201810
20192
20206
20214
20226
20234
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed85

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
Hoffmann-La Roche9
Amgen5
GlaxoSmithKline5
AstraZeneca4
Chinese University of Hong Kong4
Lee's Pharmaceutical Limited4
Assembly Biosciences2
Biogen2
Boehringer Ingelheim2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B, Chronic13
Carcinoma, Hepatocellular9
Hepatitis B7
Carcinoma, Non-Small-Cell Lung5
Liver Neoplasms5
Neoplasms5
Breast Neoplasms3
Lymphoma, Non-Hodgkin3
Cholangiocarcinoma2
Kidney Neoplasms2

Trials

Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.